Radnor Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $66.7M | Sell |
518,900
-543
| -0.1% | -$63.6K | 9.36% | 1 |
|
|
2026
Q1 | $62.5M | Sell |
519,443
-115
| -0% | -$13.3K | 9.25% | 1 |
|
|
2025
Q4 | $54.7M | Sell |
519,558
-1,491
| -0.3% | -$140K | 8.12% | 1 |
|
|
2025
Q3 | $43.7M | Sell |
521,049
-1,659
| -0.3% | -$137K | 6.65% | 1 |
|
|
2025
Q2 | $41.4M | Buy |
522,708
+15,210
| +3% | +$1.21M | 6.6% | 1 |
|
|
2025
Q1 | $45.6M | Sell |
507,498
-13,268
| -3% | -$1.24M | 7.63% | 1 |
|
|
2024
Q4 | $51.8M | Sell |
520,766
-9,744
| -2% | -$1M | 8.66% | 1 |
|
|
2024
Q3 | $60.2M | Buy |
530,510
+10,827
| +2% | +$1.29M | 8.95% | 1 |
|
|
2024
Q2 | $64.3M | Sell |
519,683
-9,918
| -2% | -$1.28M | 19.62% | 1 |
|
|
2024
Q1 | $69.9M | Sell |
529,601
-17,933
| -3% | -$2.21M | 11.92% | 1 |
|
|
2023
Q4 | $59.7M | Sell |
547,534
-17,248
| -3% | -$1.79M | 11.13% | 1 |
|
|
2023
Q3 | $58.1M | Sell |
564,782
-6,895
| -1% | -$743K | 11.57% | 1 |
|
|
2023
Q2 | $66M | Sell |
571,677
-15,468
| -3% | -$1.76M | 28.19% | 1 |
|
|
2023
Q1 | $62.5M | Sell |
587,145
-6,783
| -1% | -$732K | 16.43% | 1 |
|
|
2022
Q4 | $65.9M | Sell |
593,928
-710
| -0.1% | -$72.6K | 16.12% | 1 |
|
|
2022
Q3 | $51.2M | Buy |
594,638
+281
| +0% | +$25.1K | 14.85% | 1 |
|
|
2022
Q2 | $54.2M | Sell |
594,357
-20,521
| -3% | -$1.82M | 14.82% | 1 |
|
|
2022
Q1 | $50.5M | Sell |
614,878
-29,280
| -5% | -$2.31M | 12.66% | 1 |
|
|
2021
Q4 | $49.4M | Sell |
644,158
-15,383
| -2% | -$1.23M | 12.19% | 1 |
|
|
2021
Q3 | $49.5M | Buy |
659,541
+42,158
| +7% | +$3.21M | 29.42% | 1 |
|
|
2021
Q2 | $48M | Sell |
617,383
-28,534
| -4% | -$2.12M | 16.21% | 1 |
|
|
2021
Q1 | $47.5M | Sell |
645,917
-344,935
| -35% | -$25.4M | 15.28% | 1 |
|
|
2020
Q4 | $77.3M | Buy |
990,852
+351,978
| +55% | +$26.9M | 21.82% | 1 |
|
|
2020
Q3 | $50.6M | Sell |
638,874
-2,078
| -0.3% | -$163K | 16.94% | 1 |
|
|
2020
Q2 | $47.8M | Sell |
640,952
-1,238
| -0.2% | -$93.2K | 17.26% | 1 |
|
|
2020
Q1 | $47.1M | Sell |
642,190
-18,759
| -3% | -$1.47M | 19.35% | 1 |
|
|
2019
Q4 | $57.4M | Sell |
660,949
-5,463
| -0.8% | -$449K | 17.78% | 1 |
|
|
2019
Q3 | $53.5M | Buy |
666,412
+5,579
| +0.8% | +$447K | 17.54% | 1 |
|
|
2019
Q2 | $52.9M | Sell |
660,833
-23,690
| -3% | -$1.81M | 17.4% | 1 |
|
|
2019
Q1 | $54.3M | Sell |
684,523
-34,647
| -5% | -$2.59M | 17.78% | 1 |
|
|
2018
Q4 | $52.4M | Sell |
719,170
-10,441
| -1% | -$737K | 18.92% | 1 |
|
|
2018
Q3 | $49.4M | Buy |
729,611
+15,163
| +2% | +$966K | 15.71% | 1 |
|
|
2018
Q2 | $41.4M | Sell |
714,448
-40,631
| -5% | -$2.29M | 15.34% | 1 |
|
|
2018
Q1 | $39.2M | Sell |
755,079
-1,399
| -0.2% | -$75.6K | 13.34% | 1 |
|
|
2017
Q4 | $40.6M | Buy |
756,478
+493
| +0.1% | +$27.3K | 13% | 1 |
|
|
2017
Q3 | $46.2M | Hold |
755,985
| – | – | 15.65% | 1 |
|
|
2017
Q2 | $46.2M | Sell |
755,985
-11,623
| -2% | -$708K | 15.65% | 1 |
|
|
2017
Q1 | $46.5M | Sell |
767,608
-44,120
| -5% | -$2.68M | 15.72% | 1 |
|
|
2016
Q4 | $45.6M | Buy |
+811,728
| New | +$47.5M | 15.6% | 1 |
|
Other funds holding MRK
LMFP
AAMU
CRM
SP
ORIO
CNB
Radnor Capital Management's MRK Position: Q2 2026 in Review
Radnor Capital Management reduced its Merck (MRK) stake by 0.1% in Q2 2026, selling an estimated $63.6K and leaving 518,900 shares worth $66.7M. The position accounts for 9.36% of the portfolio, ranked #1.
Radnor Capital Management first reported a position in MRK in Q4 2016 and has held it in 39 quarters since. The position peaked at $77.3M in Q4 2020. 711 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Radnor Capital Management held 518,900 shares of Merck worth $66.7M as of Q2 2026.
- Radnor Capital Management sold 543 Merck shares in Q2 2026, an estimated $63.6K.
- Merck made up 9.36% of Radnor Capital Management's portfolio in Q2 2026, its #1 holding.
- Radnor Capital Management first reported a position in Merck in Q4 2016 and has held it in 39 quarters since.
- Radnor Capital Management's Merck position peaked at $77.3M in Q4 2020.
- 711 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Radnor Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.